PubMed:9746760
Annnotations
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 1678-1682 | gene:2532 | denotes | DARC |
| T1 | 1705-1712 | disease:C0024530 | denotes | malaria |
| R1 | T0 | T1 | associated_with | DARC,malaria |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 47-58 | DNA | denotes | FY*B allele |
| T2 | 66-95 | DNA | denotes | Duffy chemokine receptor gene |
| T3 | 222-232 | protein | denotes | Antibodies |
| T4 | 236-250 | protein | denotes | Duffy antigens |
| T5 | 348-361 | protein | denotes | Duffy protein |
| T6 | 384-428 | protein | denotes | Plasmodium vivax erythrocyte-binding protein |
| T7 | 464-474 | protein | denotes | chemokines |
| T8 | 489-526 | protein | denotes | Duffy Antigen Receptor for Chemokines |
| T9 | 528-532 | protein | denotes | DARC |
| T10 | 544-570 | protein | denotes | Duffy polymorphic antigens |
| T11 | 572-575 | protein | denotes | Fya |
| T12 | 580-583 | protein | denotes | Fyb |
| T13 | 598-619 | DNA | denotes | FY*A and FY*B alleles |
| T14 | 637-658 | protein | denotes | erythrocyte membranes |
| T15 | 885-898 | DNA | denotes | FY*B promoter |
| T16 | 906-914 | DNA | denotes | GATA box |
| T17 | 948-973 | protein | denotes | erythrocyte Duffy protein |
| T18 | 1025-1045 | DNA | denotes | FY*B coding sequence |
| T19 | 1216-1235 | DNA | denotes | wild-type FY*B GATA |
| T20 | 1347-1417 | DNA | denotes | restriction enzyme-generated restriction fragment length polymorphisms |
| T21 | 1567-1571 | protein | denotes | DARC |
| T22 | 1678-1682 | protein | denotes | DARC |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 9746760-11#67#71#gene2532 | 1678-1682 | gene2532 | denotes | DARC |
| 9746760-11#94#101#diseaseC0024530 | 1705-1712 | diseaseC0024530 | denotes | malaria |
| 67#71#gene253294#101#diseaseC0024530 | 9746760-11#67#71#gene2532 | 9746760-11#94#101#diseaseC0024530 | associated_with | DARC,malaria |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-148 | Sentence | denotes | A novel mutation in the coding sequence of the FY*B allele of the Duffy chemokine receptor gene is associated with an altered erythrocyte phenotype. |
| S2 | 149-221 | Sentence | denotes | The Duffy blood group system is of clinical and biological significance. |
| S3 | 222-343 | Sentence | denotes | Antibodies to Duffy antigens are responsible for some cases of transfusion incompatibility and newborn hemolytic disease. |
| S4 | 344-535 | Sentence | denotes | The Duffy protein is a receptor for the Plasmodium vivax erythrocyte-binding protein and is also a receptor for various chemokines (thus renamed Duffy Antigen Receptor for Chemokines [DARC]). |
| S5 | 536-659 | Sentence | denotes | The two Duffy polymorphic antigens, Fya and Fyb (coded by the FY*A and FY*B alleles), are present on erythrocyte membranes. |
| S6 | 660-818 | Sentence | denotes | The Fy(a-b-) phenotype is the predominant one in populations of black people and also occurs in other populations, including some non-Ashkenazi Jewish groups. |
| S7 | 819-974 | Sentence | denotes | The Fy(a-b-) phenotype has been associated with a mutation in the FY*B promoter at the GATA box that abolishes the expression of erythrocyte Duffy protein. |
| S8 | 975-1159 | Sentence | denotes | We describe here a novel mutation, present in the FY*B coding sequence (271C --> T), that is associated with some Fy(b-) phenotypes among non-Ashkenazi Jews and among Brazilian blacks. |
| S9 | 1160-1295 | Sentence | denotes | The mutation is present in Fy(b-) individuals, who have wild-type FY*B GATA and carry the previously described 304G --> A substitution. |
| S10 | 1296-1418 | Sentence | denotes | The 271C --> T and 304G --> A can be identified by restriction enzyme-generated restriction fragment length polymorphisms. |
| S11 | 1419-1610 | Sentence | denotes | The 271C --> T substitution represents a considerable change in chemical nature (Arg91 --> Cys), one which may affect the antigenic determinants of DARC, and thus be of clinical significance. |
| S12 | 1611-1760 | Sentence | denotes | The mutation may have implications for some physiological roles of DARC and be of interest in malaria research and in studies of population genetics. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 344-361 | NP | denotes | The Duffy protein |
| C2 | 536-570 | NP | denotes | The two Duffy polymorphic antigens |
| C3 | 572-620 | NP | denotes | Fya and Fyb (coded by the FY*A and FY*B alleles) |
| C4 | 867-914 | NP | denotes | a mutation in the FY*B promoter at the GATA box |
| C5 | 915-919 | NP | denotes | that |
| C6 | 992-1008 | NP | denotes | a novel mutation |
| C7 | 1060-1064 | NP | denotes | that |
| C8 | 1187-1205 | NP | denotes | Fy(b-) individuals |
| C9 | 1207-1210 | NP | denotes | who |
| C10 | 1458-1514 | NP | denotes | a considerable change in chemical nature (Arg91 --> Cys) |
| C11 | 1516-1519 | NP | denotes | one |
| C12 | 1520-1525 | NP | denotes | which |
| C13 | 1567-1571 | NP | denotes | DARC |
| C14 | 1678-1682 | NP | denotes | DARC |
| R1 | C3 | C2 | coref-appos | Fya and Fyb (coded by the FY*A and FY*B alleles),The two Duffy polymorphic antigens |
| R2 | C5 | C4 | coref-relat | that,a mutation in the FY*B promoter at the GATA box |
| R3 | C7 | C6 | coref-relat | that,a novel mutation |
| R4 | C9 | C8 | coref-relat | who,Fy(b-) individuals |
| R5 | C11 | C10 | coref-pron | one,a considerable change in chemical nature (Arg91 --> Cys) |
| R6 | C12 | C10 | coref-relat | which,a considerable change in chemical nature (Arg91 --> Cys) |
| R7 | C13 | C1 | coref-ident | DARC,The Duffy protein |
| R8 | C14 | C13 | coref-ident | DARC,DARC |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 47-58 | DNA_domain_or_region | denotes | FY*B allele |
| T2 | 66-95 | DNA_domain_or_region | denotes | Duffy chemokine receptor gene |
| T3 | 126-147 | other_name | denotes | erythrocyte phenotype |
| T4 | 153-177 | other_name | denotes | Duffy blood group system |
| T5 | 197-220 | other_name | denotes | biological significance |
| T6 | 222-232 | protein_family_or_group | denotes | Antibodies |
| T7 | 236-250 | protein_family_or_group | denotes | Duffy antigens |
| T8 | 285-312 | other_name | denotes | transfusion incompatibility |
| T9 | 317-342 | other_name | denotes | newborn hemolytic disease |
| T10 | 348-361 | protein_molecule | denotes | Duffy protein |
| T11 | 384-428 | protein_molecule | denotes | Plasmodium vivax erythrocyte-binding protein |
| T12 | 464-474 | protein_family_or_group | denotes | chemokines |
| T13 | 489-526 | protein_molecule | denotes | Duffy Antigen Receptor for Chemokines |
| T14 | 528-532 | protein_molecule | denotes | DARC |
| T15 | 544-570 | protein_family_or_group | denotes | Duffy polymorphic antigens |
| T16 | 572-575 | protein_molecule | denotes | Fya |
| T17 | 580-583 | protein_molecule | denotes | Fyb |
| T18 | 637-658 | protein_family_or_group | denotes | erythrocyte membranes |
| T19 | 664-682 | other_name | denotes | Fy(a-b-) phenotype |
| T20 | 724-736 | multi_cell | denotes | black people |
| T21 | 790-817 | multi_cell | denotes | non-Ashkenazi Jewish groups |
| T22 | 823-841 | other_name | denotes | Fy(a-b-) phenotype |
| T23 | 885-898 | DNA_domain_or_region | denotes | FY*B promoter |
| T24 | 906-914 | DNA_domain_or_region | denotes | GATA box |
| T25 | 948-959 | protein_molecule | denotes | erythrocyte |
| T26 | 960-973 | protein_molecule | denotes | Duffy protein |
| T27 | 994-1008 | other_name | denotes | novel mutation |
| T28 | 1025-1045 | DNA_domain_or_region | denotes | FY*B coding sequence |
| T29 | 1047-1051 | nucleotide | denotes | 271C |
| T30 | 1056-1057 | nucleotide | denotes | T |
| T31 | 1089-1106 | other_name | denotes | Fy(b-) phenotypes |
| T32 | 1113-1131 | multi_cell | denotes | non-Ashkenazi Jews |
| T33 | 1142-1158 | multi_cell | denotes | Brazilian blacks |
| T34 | 1187-1205 | multi_cell | denotes | Fy(b-) individuals |
| T35 | 1216-1235 | DNA_domain_or_region | denotes | wild-type FY*B GATA |
| T36 | 1271-1275 | nucleotide | denotes | 304G |
| T37 | 1280-1281 | nucleotide | denotes | A |
| T38 | 1282-1294 | other_name | denotes | substitution |
| T39 | 1300-1304 | nucleotide | denotes | 271C |
| T40 | 1309-1310 | nucleotide | denotes | T |
| T41 | 1315-1319 | nucleotide | denotes | 304G |
| T42 | 1324-1325 | nucleotide | denotes | A |
| T43 | 1347-1417 | DNA_family_or_group | denotes | restriction enzyme-generated restriction fragment length polymorphisms |
| T44 | 1423-1427 | nucleotide | denotes | 271C |
| T45 | 1432-1433 | nucleotide | denotes | T |
| T46 | 1500-1505 | amino_acid_monomer | denotes | Arg91 |
| T47 | 1510-1513 | amino_acid_monomer | denotes | Cys |
| T48 | 1567-1571 | protein_molecule | denotes | DARC |
| T49 | 1678-1682 | protein_molecule | denotes | DARC |
| T50 | 1705-1721 | other_name | denotes | malaria research |
| T51 | 1740-1759 | other_name | denotes | population genetics |